In AD brains, the somatic mutations found in mtDNA are higher than in healthy brains, potentially triggering other neuropathological consequences such as the increased ROS production in neurons and the promotion of amyloidogenic processing of APP (Lin et al., 2002). The gene discussed is APP; the disease is Alzheimer disease.